Advance Search
GU Xin, JING Liwei, WANG Andi, LIU Jun, DAI Yongqiang, ZHANG Baoling. Analysis of the recurrence rate and risk factors of renal calculi after intracavitary lithotripsy[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 39-41. DOI: 10.7619/jcmp.20232864
Citation: GU Xin, JING Liwei, WANG Andi, LIU Jun, DAI Yongqiang, ZHANG Baoling. Analysis of the recurrence rate and risk factors of renal calculi after intracavitary lithotripsy[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 39-41. DOI: 10.7619/jcmp.20232864
shu

Analysis of the recurrence rate and risk factors of renal calculi after intracavitary lithotripsy

  • the Second Department of Urological Surgery, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province, Cangzhou, Hebei, 061000

More Information
  • Received Date: September 08, 2023
  • Revised Date: October 22, 2023
  • Available Online: November 26, 2023
    Graphical Abstract
    • Abstract
  • Objective 

    To investigate the incidence and risk factors of recurrence of renal calculi after intracavitary lithotripsy.

    Methods 

    The clinical data of 190 patients with renal stones who underwent endoluminal lithotripsy in our hospital were retrospectively collected. Based on the results of CT, B-ultrasound, or X-ray examination of the urinary system during the 2-year follow-up period, therecurrence of renal calculi was analyzed. Univariate and multivariate Logistic regression were used to analyze the risk factors of stone recurrence.

    Results 

    of 190 patients, 49 patients experienced stone recurrence within 2 years after surgery, with a recurrence rate of 25.79%. Univariate Logistic regression analysis showed that body mass index(BMI), diabetes, smoking, older age and hypertension were protective factors for stone recurrence. Multivariate Logistic regression analysis showed that diabetes and smoking were risk factors for stone recurrence, while age and hypertension were protective factors for stone recurrence.

    Conclusion 

    The recurrence of renal stone after intracavitary lithotripsy is common. Diabetes and smoking are risk factors for the recurrence of renal stone, while older age and hypertension are protective factors.

    • FullText(HTML)
    • References (16)
  • [1]
    LIN C Y, JUAN Y S, HUANG T Y, et al. The influence of climatic factors in the seasonal fluctuation of urolithiasis and the trend of stone disease management in the southern Taiwan[J]. Urolithiasis, 2023, 51(1): 55. doi: 10.1007/s00240-023-01416-8
    [2]
    ZENG G, MAI Z, XIA S, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study[J]. BJU Int, 2017, 120(1): 109-16. doi: 10.1111/bju.13828
    [3]
    输尿管软镜碎石术后应用滋肾通淋排石汤的排石效果研究[J]. 实用临床医药杂志, 2020, 24(22): 93-96.
    [4]
    CHEWCHARAT A, CURHAN G. Trends in the prevalence of kidney stones in the United States from 2007 to 2016[J]. Urolithiasis, 2021, 49(1): 27-39. doi: 10.1007/s00240-020-01210-w
    [5]
    马海红, 轩诗孟, 张温花. 肾结石术后复发的影响因素分析[J]. 护理实践与研究, 2022, 19(5): 651-654. https://www.cnki.com.cn/Article/CJFDTOTAL-HLSJ202205005.htm
    [6]
    SONG S, THOMAS I C, GANESAN C, et al. Twenty-four-hour urine testing and urinary stone disease recurrence in veterans[J]. Urology, 2022, 159: 33-40. doi: 10.1016/j.urology.2021.10.005
    [7]
    D'AMBROSIO V, FERRARO P M, LOMBARDI G, et al. Unravelling the complex relationship between diet and nephrolithiasis: the role of nutrigenomics and nutrigenetics[J]. Nutrients, 2022, 14(23): 4961. doi: 10.3390/nu14234961
    [8]
    杜伟, 李东, 宋小松, 等. 泌尿系结石成分与代谢异常的临床研究[J]. 中华肥胖与代谢病电子杂志, 2018, 4(1): 35-39. https://www.cnki.com.cn/Article/CJFDTOTAL-FPDX201801009.htm
    [9]
    PRASANCHAIMONTRI P, MONGA M. Predictive Factors for Kidney Stone Recurrence in Type 2 Diabetes Mellitus[J]. Urology, 2020, 143: 85-90. doi: 10.1016/j.urology.2020.04.067
    [10]
    罗敏, 苟淼, 沈鹏飞, 等. 代谢综合征与泌尿系结石的危险因素及结石成分的关系[J]. 四川医学, 2018, 39(2): 4-4. https://www.cnki.com.cn/Article/CJFDTOTAL-SCYX201802011.htm
    [11]
    IREMASHVILI V, LI S, BEST S L, et al. Clinical and demographic predictors of repeat stone surgery[J]. BJU Int, 2019, 124(5): 836-841. doi: 10.1111/bju.14844
    [12]
    CUPISTI A, D'ALESSANDRO C, SAMONI S, et al. Nephrolithiasis and hypertension: possible links and clinical implications[J]. Journal of nephrology, 2014, 27(5): 477-482. doi: 10.1007/s40620-014-0068-x
    [13]
    NEVO A, LEVI O, SIDI A, et al. Patients treated for uric acid stones reoccur more often and within a shorter interval compared to patients treated for calcium stones[J]. Canadian Urological Association journal=Journal de l'Association des urologues du Canada, 2020, 14(11): E555.
    [14]
    李剑, 曹景宏, 陈欣. 基于结石成分分析和尿液理化性质检测与饮食干预对预防泌尿系结石复发的探讨[J]. 中国预防医学杂志, 2020, 21(9): 1063-1066. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYC202009029.htm
    [15]
    DETSYK O, SOLOMCHAK D. The impact of cigarette smoking, alcohol drinking and physical inactivity on the risk of urolithiasis occurrence and recurrence[J]. Wiadomoscilekarskie (Warsaw, Poland: 1960), 2017, 70(1): 38-42.
    [16]
    KANG H W, SEO S P, KIM W T, et al. Metabolic Characteristics and Risks Associated with Stone Recurrence in Korean Young Adult Stone Patients[J]. J Endourol, 2017, 31(8): 806-811.
    • Related Articles

  • Related Articles

    [1]YAO Binbin, SHEN Yan, YANG Hongli, FENG Sujuan, HUANG Huaxing, ZHU Xueling, SHEN Lianglan. Impact of serum cystatin C and hypersensitivity C-reactive protein on the 3-year survival of patients undergoing maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 68-75, 80. DOI: 10.7619/jcmp.20240283
    [2]QIN Suping. Research on levels of C reactive protein and homocysteine in elderly patients with dementia[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 56-58. DOI: 10.7619/jcmp.202011015
    [3]CHENG Baoxiang, CAO Lei. Expression characteristics of serum homocysteine and hypersensitive C reactive protein in patients with coronary atherosclerotic heart disease and clinical significance[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 94-97. DOI: 10.7619/jcmp.202006026
    [4]QIU Yuan, LI Li, ZENG Laixing. Changes of C reactive protein and serum procalcitoninin patients with severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2019, 23(12): 62-64. DOI: 10.7619/jcmp.201912018
    [5]MENG Xiangzhong, WEI Feng, WANG Na, SHI Zhenhua, DING Dongrui. Clinical analysis of plasma procalcitonin and C-reactive protein levels in 65 patients with septic shock[J]. Journal of Clinical Medicine in Practice, 2018, (3): 120-122. DOI: 10.7619/jcmp.201803035
    [6]LIU Li, LIU Mingxin, NIU Shihui, LU Zejun, WANG Nana, ZHANG Ling. Effect of irbesartan combined with atorvastatin on C reactive protein and cystatin C of patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2017, (21): 33-35. DOI: 10.7619/jcmp.201721009
    [7]LU Yunnan, HUA Ye, FENG Zhiqiang, MA Tao, HE Peicheng, WU Shuangshuang, XU Hong. Effect of edaravone combined with statins on serum homocysteine, C-reactive protein and lipid levels in patients with ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2017, (19): 27-30. DOI: 10.7619/jcmp.201719008
    [8]LI Zhi. Changes and diagnostic value of serum procalcitonin and C-reactive protein in patients with severe infection in ICU[J]. Journal of Clinical Medicine in Practice, 2016, (5): 70-72. DOI: 10.7619/jcmp.201605021
    [9]SHEN Xin, HU Bingbing. Clinical significance of detecting homocysteine, C-reactive protein and ankle brachial index in elderly patients with lower limb artherosclerosis[J]. Journal of Clinical Medicine in Practice, 2014, (16): 47-49. DOI: 10.7619/jcmp.201416013
    [10]LV Guoling, HUO Zhenglu. Study on the levels and influencing factors of serum cystatin C, homocysteine and acute phase C reactive protein in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2013, (11): 12-14. DOI: 10.7619/jcmp.201311004

  • Cited by

    Periodical cited type(17)

    1. 陈海明，杨凯，王华，王德发，郭春华. 补阳还五汤联合针灸康复治疗脑卒中偏瘫的效果及对患者运动功能、生活质量的影响. 大医生. 2025(01): 94-96 .
    2. 霍尚飞，葛青叶，罗贺艳，刘敏. 扶正补土针灸联合经颅磁刺激治疗脑卒中后手功能障碍临床研究. 新中医. 2025(02): 118-122 .
    3. 王周红，张海玲. 针灸联合康复运动训练治疗脑卒中后偏瘫的效果观察. 中国基层医药. 2025(01): 77-82 .
    4. 朱敏. 中医针灸与康复训练结合标准化治疗脑卒中的临床疗效探究. 中国标准化. 2025(04): 321-324 .
    5. 张丽苹，龚丹. 通络扶正汤配合针灸辅治缺血性脑卒中后偏瘫痰热瘀阻证临床观察. 实用中医药杂志. 2025(02): 293-295 .
    6. 王少儿，王飞，邓艳，陈琼凤. 醒神通经导气针法联合艾灸治疗气虚血瘀型卒中后偏瘫临床研究. 新中医. 2025(05): 151-156 .
    7. 赵莉. 头皮针抽提法结合体针治疗脑卒中后肢体功能障碍的临床观察. 实用中西医结合临床. 2025(02): 49-51+94 .
    8. 温瑞丽，陈启波，李强，陈丽，古丽红，梁万仟. 扶正补土针灸法联合任务导向性镜像疗法对老年卒中后偏瘫患者上肢功能的影响. 河北中医. 2024(03): 460-463 .
    9. 王琨，任静，于文琪，徐大伟，孙慧. 参芪桃花四物汤合复遂汤联合针刺对气虚血瘀证缺血性脑梗死恢复期痉挛性瘫痪患者的临床疗效. 中成药. 2024(06): 1867-1872 .
    10. 徐滢，夏源源. 针康法对脑卒中下肢痉挛患者下肢运动功能和肌张力的影响. 现代医学与健康研究电子杂志. 2024(13): 92-94 .
    11. 刘莲. 针灸推拿辅治脑卒中后偏瘫临床观察. 实用中医药杂志. 2024(07): 1387-1389 .
    12. 胡晓亭. 补阳还五汤配合针灸治疗脑梗死偏瘫患者的效果及影响. 临床研究. 2024(08): 114-117 .
    13. 郑伟挺. 血府逐瘀汤加减配合偏瘫肢体康复训练对脑梗死后偏瘫患者神经功能、肢体运动功能的影响分析. 中国现代药物应用. 2024(19): 113-116 .
    14. 田亚黎. 旋转对折埋线联合高压氧治疗脑卒中后运动障碍的临床观察. 中国疗养医学. 2024(12): 40-43 .
    15. 陈玮琪. 运动疗法联合中医针灸治疗中风后肢体运动功能障碍的效果研究. 内蒙古中医药. 2024(11): 127-128 .
    16. 王凡，李朝阳，蒋腾，王山，刘熠. 针刺健侧下肢治疗中风后上肢软瘫的临床研究. 医药论坛杂志. 2024(24): 2677-2680 .
    17. 刘文娜，宋霞. 任务导向性训练与扶正补土针灸在脑梗死偏瘫患者康复治疗中的应用效果. 中国卫生标准管理. 2024(23): 160-163 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (281) PDF downloads (16) Cited by(17)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return